Company Profile
Management Team
Board of Directors
Background
Copper Chelator Based Technology
NAM Based Technology
Pipeline Overview
StemEx®
NiCord®
CordBridge™
NK Cell Product
Press Releases
Press Coverage
Events
Publications
Home
About Us
Technology
Pipeline Products
News & Publications
Contact Us
• Press Releases
• Press Coverage
• Events
• Publications
Scientific Publications
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine- a phase I-II clinical trial
Nicotinamide Modulates Ex-Vivo Expansion of Cord Blood Derived CD34+ Cells Cultured with Cytokines and Promotes Their Homing and Engraftment in SCID Mice
Antagonists to Retinoid Receptors Down-Regulate CD38 Expression and Inhibit In Vitro Differentiation of Cord Blood Derived CD34+ Cells
NICOTINAMIDE ATTENUATES IN VITRO DIFFERENTIATION AND ELEVATES BONE MARROW HOMING POTENTIAL OF CULTURED CD34+ CELLS
Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells
Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. Br J Haematol. 2002;116:655-661
Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34(+) cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol. 2004;32:547-55
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 2004;6:344-55
The Effect of Tetraethylenepentamine, a Synthetic Copper Chelating Polyamine, on Expression of CD34 and CD38 Antigens on Normal and Leukemic Hematopoietic Cells Leukemia & Lymphoma, March 2004 Vol. 45 (3), pp. 583–589
Nicotinamide, a Specific Inhibitor of NAD(+)-Dependent ADP-ribosyl Transferases Promotes Ex-Vivo Expansion of Early Subsets of Hemopoietic CD34+ Cells
Ex-vivo Expanded Human Bone Marrow-Derived CD133+ Cells Improve Cardiac Function in Rats With Acute Myocardial Infarction
To learn more about our products and clinical trials, please fill in:
*
Name:
*
Email:
Country:
*
Message:
*
Please type in the verification code as appears on the image:
©
Gamida Cell
-
Stem Cell Therapy
. All rights reserved. |
Disclaimer
|
Sitemap
Page Top
|
Print
|
Website by
Volle'